These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31604805)

  • 1. Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis.
    Tao XR; Rong JB; Lu HS; Daugherty A; Shi P; Ke CL; Zhang ZC; Xu YC; Wang JA
    J Lipid Res; 2019 Dec; 60(12):1983-1995. PubMed ID: 31604805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensinogen Exerts Effects Independent of Angiotensin II.
    Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
    Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
    Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo.
    Wu C; Xu Y; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Vander Kooi CW; Cassis LA; Wang JA; Daugherty A
    Hypertension; 2015 Apr; 65(4):800-5. PubMed ID: 25691624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro.
    Wei D; Wu S; Liu J; Zhang X; Guan X; Gao L; Xu Z
    Can J Physiol Pharmacol; 2021 Aug; 99(8):775-785. PubMed ID: 33290156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice.
    Kang S; Lee AY; Park SY; Liu KH; Im DS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting arginase-II protects mice from high-fat-diet-induced hepatic steatosis through suppression of macrophage inflammation.
    Liu C; Rajapakse AG; Riedo E; Fellay B; Bernhard MC; Montani JP; Yang Z; Ming XF
    Sci Rep; 2016 Feb; 6():20405. PubMed ID: 26846206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet.
    Hao T; Chen H; Wu S; Tian H
    Mol Med Rep; 2019 Jul; 20(1):701-708. PubMed ID: 31180545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis.
    Shu Y; Hassan F; Coppola V; Baskin KK; Han X; Mehta NK; Ostrowski MC; Mehta KD
    Mol Metab; 2021 Feb; 44():101133. PubMed ID: 33271332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Amino Acids Proximate to the Renin Cleavage Site of Human Angiotensinogen Do Not Affect Blood Pressure and Atherosclerosis in Mice-Brief Report.
    Wu CH; Wu C; Howatt DA; Moorleghen JJ; Cassis LA; Daugherty A; Lu HS
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2108-2113. PubMed ID: 32640904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
    Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
    Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
    Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
    EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Chi X; Qu N; Wang C
    Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
    Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression.
    Luan H; Huo Z; Zhao Z; Zhang S; Huang Y; Shen Y; Wang P; Xi J; Liang J; Wu F
    Phytother Res; 2020 Jun; 34(6):1455-1466. PubMed ID: 31828866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.